NINTH MEETING OF INDIA-US HIGH TECHNOLGOY COOPERATION GROUP OVERALL PROGRAMME

Transcription

1 NINTH MEETING OF INDIA-US HIGH TECHNOLGOY COOPERATION GROUP Thursday, November 20 th, 2014: Taj Mahal Hotel, Mansingh Road, New Delhi OVERALL PROGRAMME hrs Registration hrs Diwan-I-Am Opening Plenary Session: Remarks by Mr Sidharth Birla, President, FICCI Remarks by Chandrajit Banerjee DG, CII Remarks by Ms Dianne Farell, President (Acting), USIBC Address by Mr Eric L. Hirschhorn, Under Secretary for Bureau of Industry and Security, US Department of Commerce Address by Mrs Sujatha Singh, Foreign Secretary, Govt. of India Concluding Remarks by Dr A. Didar Singh, Secretary General, FICCI hrs Tea/Coffee Break hrs Sector Specific Breakout Sessions Diwan-I-Am Diwan-I-Khas Life Sciences: Industry Co-chairs : Representatives from the relevant GoI Departments to be present as Observers. Defence and Strategic Trade: Industry Co-chairs Representatives from the relevant GoI Departments to be present as Observers hrs Lunch hrs Break-out Sessions to continue: To culminate in framing specific Industry recommendations to GoI & USG hrs Break

2 hrs Hitech Manufacturing: Joint Session( Both Government and Business Sector to participate) Hitech Manufacturing Sector in India: Prospects and Policies- A broad overview of the Make in India Program: Opening remarks by the Government lead in GoI & relevant USG official to co-lead Aerospace sector: Aircrafts/UAVs/Aero Engines/MROs Presentation by Indian Machine Tools Manufacturers Association & Presentation/response by the US Industry Material Sciences/Advanced Electronics

3 NINTH MEETING OF INDIA-US HIGH TECHNOLGOY COOPERATION GROUP Thursday, November 20 th, 2014 : Taj Mahal Hotel, Mansingh Road, New Delhi hrs Introductory Remarks by hrs Break out Session on Lifesciences Session Coordinator: FICCI Indian Private Sector Chair: Ms. Sushma Berlia, President, Apeejay Stya Group* U.S. Private Sector Chair: Mr. Sanjay Banerjee, Regional Managing Director- South Asia, Zimmer hrs Make in India: Creating the Foundations and Framework for an Innovative Med-Tech and Health IT Industry The Government of India has rightfully identified medical devices as one of the key sunshine sectors for its Make in India campaign. Clinicians, researchers, and technology experts are the building blocks for a collaborative and innovative medical device and medical technology industry. A predictable regulatory environment, including the sharing of best practices in standardization, and recognition of the device industry through a set of regulations and incentives distinct from drugs - is the foundation. Given these inputs, such an environment manifests itself in hubs where clinical research is fostered in areas like non-communicable diseases. Symbiotic relationships between small and large companies provide the financial backing, aside from traditional financing mechanisms, and create a start-up culture that sustains growth. Technology collaborations in assisting and incubating innovative solutions in R&D Centers and through programs like FICCI s Innovation Hack-A-Thons, as well as the facilitation of complete product design and manufacturing are the ultimate outputs of these hubs. Session Moderator Mr. Sunil Khurana, Chairman FICCI Medical Electronics Forum & Managing Director, BPL Medical Technologies Panellists Mr. Sameer Garde, President -Philips Healthcare, South Asia,Philips India Limited Dr. Karanvir Singh, Chief Medical Information Officer,Indraprastha Apollo Hospitals Mr Rajesh Taduri, Consultant Healthcare Practice, WIPRO* Sanjay Banerjee, Regional Managing Director-South Asia, Zimmer TBC: IBM, GE, Baxter hrs Skill development and Capacity building programs for Developers, Users, and Regulators in the areas of Medical Devices and Health IT

4 To enhance usability and efficacy of medical technology products in India, possible collaborations can be sought to create platforms for Training and Skill up gradation on cutting edge technologies hrs Networking Lunch Session Moderator Mr. Sunil Khurana, Chairman FICCI Medical Electronics Forum & Managing Director, BPL Medical Technologies Panellists Mr. Sameer Garde, President -Philips Healthcare, South Asia,Philips India Limited Dr. Karanvir Singh, Chief Medical Information Officer,Indraprastha Apollo Hospitals Mr Rajesh Taduri, Consultant Healthcare Practice, WIPRO* Sanjay Banerjee, Regional Managing Director-South Asia, Zimmer TBC: Medtronic, IBM, Baxter hrs R&D Foundations in Biopharmaceuticals: Building a Clinical Research Platform Clinical research is a foundation for building a thriving R&D economy where partnerships between small, medium and large scale companies flourish and high-technology trade and investment in life sciences can thrive. Since clinical research is one of the fastest growing areas in the US and many Indian companies / hospitals in India are also doing active research in this field, co-development and creation models can be facilitated between both the nations. Session Moderator Dr. Hemanth Nandigala, Co-Chair FICCI Biotech Committee and Executive Director, Virchow Biotech Panelists Dr. Shoibal Mukherjee, Independent Professional and Research Consultant Dr. Prabuddha Kundu, Cofounder & Executive Director, Premas Biotech Dr. Akhilesh D Sharma, Senior Vice President and Global Head, Dr. Reddy s Laboratories Limited Anil Seth, Senior Director Global Medical Quality, Eli Lilly TBC: Quintiles, Mylan, Actavis/Watson

5 hrs Transfer of Technology in Biopharmaceuticals: Role of the US and Indian Private Sector- How can Indian companies partner with the R&D companies in the US Through technology transfer and licensing agreements, collaboration between U.S. and Indian life sciences companies can address access concerns in the developing world. Technology transfer and collaboration allows for quicker production ramp up and streamlined regulatory approvals for Indian partner products in foreign markets. Furthermore, small, medium, and even large Research Companies who wish to develop a proof of concept for their active molecules need to develop a small scale process and purify this product and use for animal and human studies. Often these companies need to outsource this development as they are working on scarce funding. Indian CMOs can tie up with these kind of companies. *To be confirmed Session Moderator Dr. Hemanth Nandigala, Co-Chair FICCI Biotech Committee and Executive Director, Virchow Biotech o Panelists Dr. Prabuddha Kundu, Cofounder & Executive Director, Premas Biotech Dr. Shoibal Mukherjee, Independent Professional and Research Consultant Dr. Akhilesh D Sharma, Senior Vice President and Global Head, Dr. Reddy s Laboratories Limited TBC: Quintiles, Mylan, Actavis/Watson

6 NINTH MEETING OF INDIA-US HIGH TECHNOLGY COOPERATION GROUP Thursday, November 20 th, 2014 : Taj Mahal Hotel, Mansingh Road, New Delhi hrs Break out Session on Defence and Strategic Trade Session Coordinator: CII* hrs Introductory Remarks by Industry Session Co-Chairs Mr R S Bhatia, Chief Executive Officer, Bharat Forge Defence Mr. Inderjit Sial, Managing Director, Textron India Pvt Ltd hrs Defence Exports / Export Controls: A Way Forward The recently launched Defense Trade & Technology Initiative (DTTI) seeks to pursue codevelopment and co-production of advanced defense systems by both Indian and American defense industries. The Export Control Reform process has enabled a greater degree of sensitive technology to be transferred from the U.S. to India, but much more remains to be done in forming a stable and predictable technology release and licensing process. Q&A hrs Networking Lunch Indian Official Perspective Indian Industry Perspective Cmde Mukesh Bhargava (Retd), Core Member FICCI Defence & Aerospace Committee and Vice President,International Defence & Aerospace Business, Flight Systems Business Unit, Heavy Engineering IC, Larsen & Toubro Limited Arijit Ghosh, President, Honeywell Aerospace India Inderjit Sial, Managing Director, Textron India Ankur Gupta, Director, Aerospace and Defence, E&Y US Official Perspective: Deputy Assistant Secretary Matt Borman (BIS) hrs Exploring Opportunities for Co-Development & Co-Production The opportunity for U.S. and Indian industry to collaborate on the production and development of defense technologies hinges on two primary factors: Indian industry absorption capacity and U.S. licensing and release procedure. Furthermore, as Indian defense items are produced for export and integration into the global supply chain, what policy and regulatory barriers do we envision needing to address? What challenges have some major defense co-production initiatives experienced thus far? Mr HJ Kamath, Chief Executive Officer, Mahindra Telephonics Integrated Systems Limited

7 Col. (Retd.) H.S. Shankar, CEO, Alpha Design Technologies Mr Ashok Kanodia, Chairman FICCI Sub-Committee on Defence and Aerospace and CMD Precession Electronics Limited Phil Shaw, Chief Executive, Lockheed Martin India Pvt Ltd Nik Khanna, Country Executive, Raytheon Skill Development Technical training and discussion of sensitive information involves ITAR controlled release procedures. How will the U.S. export control and licensing process enable a discussion of future / projected defense capabilities, and how can Indian industry better engage U.S. defense companies on advanced joint development projects? Indian Industry Perspective US Perspective, Arijit Ghosh, President Honeywell Aerospace India Coordinate and Draft Industry Comments on Defence Trade & Manufacturing *Programme to be coordinated by CII

8 NINTH MEETING OF INDIA-US HIGH TECHNOLOGY COOPERATION GROUP Thursday, November 20 th, 2014 : Taj Mahal Hotel, Mansingh Road, New Delhi hrs -Session on Hi-Tech Manufacturing Welcome Remarks by Government Co-Chairs: Shri Vinay Kwatra, Joint Secretary (Americas), MEA, Government of India Mr Matthew Borman, Deputy Assistant Secretary of Commerce for Export Administration Topic: Developing Aerospace Supply Chain & ecosystem for manufacturing in India: Exploring Collaboration Opportunities Indian Industry Perspective on Aircraft & Component Manufacturing : Mr Sukaran Singh, VP, Tata Sons, Chairman Office & Director, Tata Advanced Systems Ltd Mr KP Mohanankrishnan- Head of business development -aero structures business Cmde Mukesh Bhargava (Retd), Core Member FICCI Defence & Aerospace Committee and Vice President,International Defence & Aerospace Business, Flight Systems Business Unit, Heavy Engineering IC, Larsen & Toubro Limited Indian Industry Perspective on MRO : Presentation by Indian MRO Player Presentation by US Industry/US Perspective Palash Roy Chowdhury, Managing Director Pratt & Whitney AVM (Rtd.) Arvind Walia, Regional Executive, Sikorsky Q&A

9 Topic: Machine Tools: cooperative possibilities [30 minutes] Presentation by the Indian Machine Tool Manufacturers Association. US Perspective/Response (Industry and Government) (USIBC Outreach to following): 1. Emerson: Pradipta Sen, President (ME/India/Africa) 2. Agilent: Anuj Sharma; Deepak Rawal 3. Cummins: Ashish Aggarwal Topic: Futuristic Technologies Indian Industry Perspective: US Perspective Mr Sanjay Sharma Associate V.P. Product Realisation, CYIENT LTD Kumar Kandaswamy, Senior Director & Team Lead-Manufacturing, Deloitte Touche Tomahatsu Dr. Ray Johnson, Chief Technology Officer, Lockheed Martin (TENTATIVE) Outreach to DuPont, Texas Instruments, Agilent, and Emerson Summation by Co-Chairs